People

hatzakis-276x303
Angelos Hatzakis, MD, PhD
National and Kapodistrian University of Athens Medical School - Professor of Epidemiology & Preventive Medicine
Education
PhD, Epidemiology, National and Kapodistrian University of Athens
MD, Medicine, National and Kapodistrian University of Athens
MSc, Epidemiology, Harvard School of Public Health
Research Interests
Epidemiology/public health, Molecular epidemiology, HIV/AIDS, Viral hepatitis
BIO
Angelos Hatzakis’ research interests cover epidemiology, virology, preventive medicine, public health of infectious diseases – especially HIV/AIDS – hepatitis and other oncogenic viruses. He has published over 280 international scientific articles and has more than 13,000 citations. Dr. Hatzakis is the founder of the National Retrovirus Reference Center, Athens, Greece; former president of the Hellenic Center for Disease Control & Prevention; founder and co-chair of “Hepatitis B & C Public Policy Association” in Luxembourg.
Publications

Recent

Papalamprakopoulou Z, Ntagianta E, Triantafyllou V, Kalamitsis G, Dharia A, Dickerson SS, Hatzakis A, Talal A (2024).
Telehealth to increase healthcare access; perspectives of people who use drugs
BMC Medical Informatics and Decision Making, 24, 306. doi: 10.1186/s12911-024-02718-6. PMCID: PMC11490127.

Roussos S, Bagos C, Bagos C..., Hatzakis A, Sypsa V (2024).
Incidence of primary hepatitis C infection among people who inject drugs during 2012-2020 in Athens, Greece
Journal of Viral Hepatitis, 31 (8), 466-476. doi: 10.1111/jvh.13951.

Kostaki EG, Roussos S, Kefala AM, Limnaios S, Psichogiou M, Papachristou E, Nikolopoulos G, Flountzi E, Friedman SR, Lagiou P, Hatzakis A, Sypsa V, Magiorkinis G, Beloukas A, Paraskevis D (2024).
Molecular epidemiology of HIV among people who inject drugs after the HIV-outbreak in Athens, Greece: Evidence for a ‘slow burn’ outbreak
Infection Genetics and Evolution, 121, 105597. doi: 10.1016/j.meegid.2024.105597.

Roussos S, Angelopoulos T, Cholongitas E, ...Hatzakis A..., Sypsa V (2024).
High levels of all-cause mortality among people who inject drugs from 2018 to 2022
International Journal of Drug Policy, 126, 104356. doi: 10.1016/j.drugpo.2024.104356.

Uuskula A, Rannap J, Weijler L..., Des Jarlais D..., Hatzakis A..., EMCDDA Study Group (2023).
Incarceration history is associated with HIV infection among community-recruited people who inject drugs in Europe: A propensity-score matched analysis of cross-sectional studies
Addiction, 118 (11), 2177-2192. doi: 10.1111/add.16283.


Notable

Hatzakis A, Sypsa V, Paraskevis D, Nikolopoulos G, Tsiara C, Micha K, Panopoulos A, Malliori M, Psichogiou M, Pharris A, Wiessing L, van de Laar M, Donoghoe M, Heckathorn DD, Friedman SR, Des Jarlais DC (2015).
Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: The ARISTOTLE programme
Addiction, 110 (9), 1453-1467. doi: 10.1111/add.12999. PMCID: PMC4854521.

Sypsa V, Paraskevis D, Malliori M, Nikolopoulos GK, Panopoulos A, Kantzanou M, Katsoulidou A, Psichogiou M, Fotiou A, Pharris A, Van De Laar M, Wiessing L, Des Jarlais D, Friedman SR, Hatzakis A (2015).
Homelessness and other risk factors for HIV infection in the current outbreak among injection drug users in Athens, Greece
American Journal of Public Health, 105 (1), 196-204. doi: 10.2105/AJPH.2013.301656. PMCID: PMC4145040.

Dr. Hatzakis' Google Scholar Profile